Gyre Therapeutics Inc (GYRE)

EBITDA Margin

-10.56%

TTM · Period ending:

GYRE logo

GYRE EBITDA Margin

Latest reported-10.56%
GYRE TTM EBITDA Margin (-2469.47% → -10.56%)
High-resolution chart · PNG

GYRE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Gyre Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-10.5618%
-0.7408%
10.7452%
12.1122%
8.9851%
16.8437%
23.3346%
17.7687%
23.0116%
22.108%
16.9572%
19.8166%
9.1099%
-1.9682%
-38.962%
-128.3631%
-1,185.3786%
-1,197.6294%
-1,194.1537%
-1,245.3601%
-1,397.7186%
-1,232.1871%
-268.1402%
-268.9856%
-263.532%
-268.9906%
885,033.3333%
812,300%
701,150%
-8,586.4198%
-3,948.2866%
-3,210.093%
-2,126.6208%
-2,535.668%
-3,269.7509%
-3,070.1786%
-4,406.2814%
-4,226.3761%
-3,925.6881%
-1,226.1383%
-746.2286%
-393.9504%
-346.4308%
-465.1521%
-1,085.7143%
-11,804.1494%
-18,356.4815%
-28,028.3333%
-1,288.5643%
-1,221.8371%
-920.1063%
-34.3289%
-5.9177%
5.7587%
2.5074%
-23.389%
-8.9577%
-0.0548%
11.9804%
18.8157%
17.6309%
-15.771%
-22.8115%
-69.3775%
-153.5791%
-134.9591%
87.2209%
87.7669%
82.4061%
186.4394%
342.1174%
1,554.9165%
-748.3349%
-762.3908%
-1,136.1762%
-3,915.9484%
-2,959.3853%
-1,186.0241%
-2,205.5127%
-1,332.2817%
-2,469.4729%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.